|
|
||||||||
The Journal of Immunology, Vol 151, Issue 7 3576-3586, Copyright © 1993 by American Association of Immunologists
ARTICLES |
L Adorini, JC Guery, S Fuchs, V Ortiz-Navarrete, GJ Hammerling and F Momburg
Preclinical Research, Sandoz Pharma Ltd., Basel, Switzerland.
To study the processing and presentation of endogenously synthesized Ag to class II MHC-restricted T cells, hen egg lysozyme (HEL), either tagged with a peptide that confers retention in the endoplasmic reticulum (HEL.KDEL), or in the secretory form (HELs), was stably expressed in LK-35.2 B hybridoma cells. Presentation of HEL peptides bound to class II molecules was assessed by activation of specific T cell hybridomas recognizing seven different epitopes derived from exogenous HEL. The presentation of endogenously synthesized HEL was not caused by reuptake of secreted of shed Ag. All the HEL epitopes examined were efficiently presented after processing of endogenous HEL by HELs-transfected LK-35.2 cells. Processing of HEL tagged with KDEL, however, gave rise to presentation of only six of the seven HEL epitopes. The epitope included in the HEL sequence 112-124 was not presented by HEL.KDEL-transfected B cells. In addition, two of the four T cell hybridomas recognizing HEL 116-129 together with I-Ak molecules were not activated by HEL.KDEL, and three other epitopes were presented with lower efficiency as compared with HELs. Thus, endogenously synthesized HEL in secretory form gives rise to a set of class II- binding epitopes indistinguishable from exogenous HEL, whereas endoplasmic reticulum-retained HEL generates a similar but not identical set of epitopes. The endosomal protease inhibitor leupeptin prevented presentation of the epitope 108-116, but not 46-61, both by HELs and HEL.KDEL transfected cells, indicating a requirement for endosomal processing in both cases. In addition, the presentation of peptides derived from endogenously synthesized, either secretory or endoplasmic reticulum-retained HEL, could be inhibited by lysosomotropic amines, further indicating that the intracellular route of class II molecules presenting peptides derived from endogenous Ag intersects the acidic endosomal compartment.
This article has been cited by other articles:
![]() |
K. R. Qazi, U. Gehrmann, E. Domange Jordo, M. C. I. Karlsson, and S. Gabrielsson Antigen-loaded exosomes alone induce Th1-type memory through a B cell-dependent mechanism Blood, March 19, 2009; 113(12): 2673 - 2683. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Wheeler, M. Rizzi, R. Sasik, G. Almanza, G. Hardiman, and M. Zanetti KDEL-Retained Antigen in B Lymphocytes Induces a Proinflammatory Response: A Possible Role for Endoplasmic Reticulum Stress in Adaptive T Cell Immunity J. Immunol., July 1, 2008; 181(1): 256 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Dolan, K. D. Gibbs Jr., and S. Ostrand-Rosenberg Tumor-Specific CD4+ T Cells Are Activated by "Cross-Dressed" Dendritic Cells Presenting Peptide-MHC Class II Complexes Acquired from Cell-Based Cancer Vaccines J. Immunol., February 1, 2006; 176(3): 1447 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Dissanayake, N. Tuera, and S. Ostrand-Rosenberg Presentation of Endogenously Synthesized MHC Class II-Restricted Epitopes by MHC Class II Cancer Vaccines Is Independent of Transporter Associated with Ag Processing and the Proteasome J. Immunol., February 15, 2005; 174(4): 1811 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Martinez-Soria, N. Ibnou-Zekri, M. Iwamoto, M.-L. Santiago-Raber, S. Kikuchi, M. Kosco-Vilbois, and S. Izui Epitope-Dependent Inhibition of T Cell Activation by the Ea Transgene: An Explanation for Transgene-Mediated Protection from Murine Lupus J. Immunol., August 15, 2004; 173(4): 2842 - 2848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Koonce, G. Wutz, E. J. Robertson, A. B. Vogt, H. Kropshofer, and E. K. Bikoff DM Loss in k Haplotype Mice Reveals Isotype-Specific Chaperone Requirements J. Immunol., April 1, 2003; 170(7): 3751 - 3761. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qi and S. Ostrand-Rosenberg H2-O Inhibits Presentation of Bacterial Superantigens, but Not Endogenous Self Antigens J. Immunol., August 1, 2001; 167(3): 1371 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rinaldi, F. Ria, P. Parrella, E. Signori, A. Serra, S. A. Ciafrè, I. Vespignani, M. Lazzari, M. G. Farace, G. Saglio, et al. Antibodies Elicited by Naked DNA Vaccination against the Complementary-determining Region 3 Hypervariable Region of Immunoglobulin Heavy Chain Idiotypic Determinants of B-lymphoproliferative Disorders Specifically React with Patients' Tumor Cells Cancer Res., February 1, 2001; 61(4): 1555 - 1562. [Abstract] [Full Text] |
||||
![]() |
E. M. Janssen, A. J. M. van Oosterhout, F. P. Nijkamp, W. van Eden, and M. H. M. Wauben The Efficacy of Immunotherapy in an Experimental Murine Model of Allergic Asthma Is Related to the Strength and Site of T Cell Activation During Immunotherapy J. Immunol., December 15, 2000; 165(12): 7207 - 7214. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qi, J.-M. Rojas, and S. Ostrand-Rosenberg Tumor Cells Present MHC Class II-Restricted Nuclear and Mitochondrial Antigens and Are the Predominant Antigen Presenting Cells In Vivo J. Immunol., November 15, 2000; 165(10): 5451 - 5461. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Guermonprez, R. Lo-Man, C. Sedlik, M.-J. Rojas, R. J. Poljak, and C. Leclerc mAb against hen egg-white lysozyme regulate its presentation to CD4+ T cells Int. Immunol., November 1, 1999; 11(11): 1863 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Panjwani, O. Akbari, S. Garcia, M. Brazil, and B. Stockinger The HSC73 Molecular Chaperone: Involvement in MHC Class II Antigen Presentation J. Immunol., August 15, 1999; 163(4): 1936 - 1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Volkmann, T. Barthlott, S. Weiss, R. Frank, and B. Stockinger Antagonist Peptide Selects Thymocytes Expressing a Class II Major Histocompatibility Complex-restricted T Cell Receptor into the CD8 Lineage J. Exp. Med., September 21, 1998; 188(6): 1083 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Accapezzato, R. Nisini, M. Paroli, G. Bruno, F. Bonino, M. Houghton, and V. Barnaba Generation of an MHC Class II-Restricted T Cell Epitope by Extracellular Processing of Hepatitis {delta} Antigen J. Immunol., June 1, 1998; 160(11): 5262 - 5266. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deussing, W. Roth, P. Saftig, C. Peters, H. L. Ploegh, and J. A. Villadangos Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation PNAS, April 14, 1998; 95(8): 4516 - 4521. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Badou, M. Savignac, M. Moreau, C. Leclerc, R. Pasquier, P. Druet, and L. Pelletier HgCl2-induced Interleukin-4 Gene Expression in T Cells Involves a Protein Kinase C-dependent Calcium Influx through L-type Calcium Channels J. Biol. Chem., December 19, 1997; 272(51): 32411 - 32418. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Villadangos, R. J. Riese, C. Peters, H. A. Chapman, and H. L. Ploegh Degradation of Mouse Invariant Chain: Roles of Cathepsins S and D and the Influence of Major Histocompatibility Complex Polymorphism J. Exp. Med., August 18, 1997; 186(4): 549 - 560. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |